Wearable Cardiac Devices Market Report 2025

The wearable cardiac devices market size has grown rapidly in recent years. It will grow from $4.74 billion in 2024 to $5.65 billion in 2025 at a compound annual growth rate (CAGR) of 19.3%. The growth during the historic period can be attributed to the increased prevalence of cardiovascular diseases, growing awareness of preventive healthcare, the integration of ECG technology into consumer electronics, increased adoption of fitness tracking devices, and a rising demand for remote patient monitoring.

The wearable cardiac devices market size is expected to see rapid growth in the next few years. It will grow to $11.31 billion in 2029 at a compound annual growth rate (CAGR) of 18.9%. The growth projected for the forecast period can be attributed to the rising adoption of telehealth services, an increasing geriatric population, integration with smartphone health ecosystems, growing demand for continuous heart health monitoring, and the expansion of telehealth and digital health platforms. Key trends during this period include the miniaturization of cardiac monitoring devices, enhanced integration with smartphones and mobile apps, development of multi-parameter monitoring wearables, wearable ECGs for arrhythmia detection, and the rise of subscription-based health monitoring services.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the wearable cardiac devices market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary artery disease, heart failure, stroke, and hypertension. This increase is mainly attributed to several risk factors, such as excessive alcohol intake, which can elevate blood pressure, cause irregular heart rhythms, and heighten the risk of heart failure and stroke. Wearable cardiac devices enable real-time monitoring of heart activity, allowing for early detection and management of cardiovascular conditions. By continuously tracking vital signs like heart rate, rhythm, and electrical signals, these devices facilitate timely medical intervention and improve patient outcomes. For example, according to the Australian Institute of Health and Welfare, a government agency, doctor-certified deaths from coronary heart disease rose from 14,100 in 2021 to 14,900 in 2022. Thus, the increasing occurrence of cardiovascular diseases is propelling the wearable cardiac devices market forward.

Key players in the wearable cardiac device market are concentrating on creating innovative products such as medical-grade smartwatches to enhance continuous heart monitoring and early diagnosis of cardiovascular issues. Medical-grade smartwatches are wearable gadgets equipped with sophisticated health sensors that meet clinical accuracy requirements for tracking vital signs such as heart rate, ECG, blood oxygen saturation, and sleep quality. These devices assist users and healthcare professionals in monitoring chronic conditions, detecting abnormalities early, and making informed health decisions based on real-time information. For instance, in July 2022, Xplore Lifestyle Solutions Pvt Ltd, an India-based manufacturer, partnered with CardiacSense, an Israeli company, to launch the CardiacSense medical watch. This device is recognized as the world’s first medically certified smartwatch for heart monitoring. It features FDA-cleared photoplethysmography (PPG) and ECG sensors that deliver hospital-grade accuracy in identifying arrhythmias, atrial fibrillation, and other cardiac abnormalities. Its proprietary algorithms enable continuous blood pressure monitoring without the need for calibration, and the sleek design supports 24/7 wearability, including fall detection and emergency SOS alerts.

In May 2024, WearLinq Inc., a US-based digital health firm specializing in wearable cardiac technology, acquired AMI Cardiac Monitoring LLC for an undisclosed price. Through this acquisition, WearLinq aimed to expand its clinical services across the US by combining AMI’s diagnostic expertise with its FDA 510(k)-cleared 6-lead ECG wearable device. AMI Cardiac Monitoring LLC is a US-based company known for offering the WearLinq eWave, a wireless 6-lead cardiac monitor designed to provide both patient comfort and clinical accuracy.

Major players in the wearable cardiac devices market are Apple Inc., Samsung Electronics Co. Ltd., Abbott Laboratories, Medtronic plc, Garmin Ltd., Masimo Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc., Biofourmis, Bittium Corporation, BPL Medical Technologies Pvt. Ltd., NeuroSky Inc., Bionet Co. Ltd., AliveCor Inc., Qardio Inc., Empatica Inc., VitalConnect Inc., Lifesignals Group, Biotricity Inc., Shimmer Research.

North America was the largest region in the wearable cardiac devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in wearable cardiac devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the wearable cardiac devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wearable cardiac devices market consists of sales of insertable cardiac monitors (ICMS), wearable ECG t-shirts, smart garments, chest strap ECG monitors, continuous blood pressure monitors, wearable telemetry devices, smart rings, ECG-enabled hearing aids, and ECG-enabled earbuds. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The wearable cardiac devices market research report is one of a series of new reports that provides wearable cardiac devices market statistics, including the wearable cardiac devices industry global market size, regional shares, competitors with the wearable cardiac devices market share, detailed wearable cardiac devices market segments, market trends, and opportunities, and any further data you may need to thrive in the wearable cardiac devices industry. These wearable cardiac devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Wearable cardiac devices are electronic medical tools that continuously track heart activity, including heart rate and rhythm, through built-in sensors. These devices can identify irregular heartbeats and, in certain cases, automatically deliver therapeutic electrical shocks to restore normal rhythm in patients at risk of sudden cardiac arrest.

The primary types of wearable cardiac devices include Holter monitors, smartwatches, patches, defibrillators, pulse oximeters, and other related products. A Holter monitor is a compact, wearable device that records heart activity continuously for 24-48 hours to detect irregular rhythms during everyday activities. These devices serve multiple purposes such as arrhythmia detection, heart rate monitoring, and managing heart diseases. They are distributed via both online and offline channels and are used by a range of end users including hospitals, clinics, individual consumers, and fitness centers.

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.